In addition to this, FGF19 (the human ortholog of FGF15) has been suggested to improve adiposity and liver steatosis in obese mouse models [26,27] and the mouse Fgf15 gene has been defined as a direct transcriptional target of VDR [28]. This evidence concerns the gene FGF19 and Hepatic steatosis.